Evaluating the rate of reversal of fentanyl-induced respiratory depression using a novel long-acting naloxone nanoparticle, cNLX-NP is a research paper published in Frontiers in Psychiatry (2024). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R21DA050565
National Institutes of Health
Grant: 5R21DA050565-02
Covalent Naloxone Nanoparticles for Next Generation Fentanyl Countermeasures
National Science Foundation
Grant: 0130903
Purchase of a 400 MHz NMR Spectrometer
National Science Foundation
Grant: 1039870
MRI: Acquisition of a New 500 MHz NMR Console and Accessories to Support Research and Education at Carnegie Mellon University
FWCI
2.51
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals